Physician profile
James Brian Frederick
NPI 1184656381
$2,940.33
in general payments reported to CMS, 2019-2025
36 companies · $529 in 2025
The $529 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $243 · 2021: $238 · 2022: $467 · 2023: $447 · 2024: $663 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,639.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $382.95 | 2024-2025 | |
| Abbvie INC. | $381.67 | 2019-2022 | |
| Astellas Pharma US INC | $307.13 | 2020-2025 | Veozah, Myrbetriq |
| Intuitive Surgical, INC. | $259.25 | 2019-2020 | |
| Exeltis, USA INC. | $167.84 | 2021-2025 | Slynd |
| Sumitomo Pharma America, INC. | $148.07 | 2023-2024 | Myfembree |
| Medtronic, INC. | $137.10 | 2022 | |
| Sage Therapeutics, LLC | $128.19 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $104.23 | 2023-2025 | |
| Gynesonics, INC. | $95.55 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $84.52 | 2019-2022 | |
| Baxter Healthcare | $74.99 | 2024-2025 | Tisseel, Perclot |
| Merck Sharp & Dohme LLC | $63.19 | 2024 | Gardasil, Gardasil 9 |
| Myovant Sciences INC. | $63.03 | 2022 | |
| Smith+Nephew, INC. | $54.17 | 2023-2025 | Pico 7 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $44.86 | 2021-2022 | |
| Pfizer INC. | $43.48 | 2023 | |
| Avion Pharmaceuticals | $42.12 | 2021-2022 | |
| Convatec INC. | $33.98 | 2022-2023 | |
| Organon LLC | $31.19 | 2024-2025 | Nexplanon |
| Amgen INC. | $29.98 | 2023 | Evenity, Prolia |
| Ortho-Clinical Diagnostics, INC. | $25.25 | 2024 | |
| Amag Pharmaceuticals, INC. | $24.38 | 2019 | |
| Myriad Genetic Laboratories, INC. | $21.08 | 2025 | Myrisk |
| Biohaven Pharmaceuticals, INC. | $21.08 | 2021 | |
| Supernus Pharmaceuticals, INC. | $20.17 | 2025 | Qelbree |
| Biohaven Pharmaceutical Holding Company LTD. | $18.78 | 2022 | |
| Axonics, INC. | $17.01 | 2023 | Bulkamid |
| Davol INC. | $16.53 | 2023 | Arista Ah Flexitip |
| Pacira Pharmaceuticals Incorporated | $16.35 | 2019 | |
| Mylan Specialty L.P. | $15.72 | 2020 | |
| Coopersurgical, INC. | $15.11 | 2023 | Advincula Delineator Uterine Manipulator |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.91 | 2021 | |
| Hologic Sales and Service, LLC | $13.61 | 2022 | |
| Avanos Medical | $12.08 | 2022 | |
| Meditrina | $10.78 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Frederick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.